Revenue
2018
2019
2020
2021
2022
2023
2024
2025
Outset Medical, Inc. (OM)
Price$3.31Cached quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $119.5M | $113.7M | $130.4M | $115.4M | $102.6M | $49.9M | $15.1M | $2.0M |
| Gross profit | $46.8M | $38.6M | $29.0M | $17.8M | $7.6M | −$13.0M | −$17.8M | −$6.1M |
| Gross margin | 39.13% | 33.92% | 22.24% | 15.46% | 7.42% | −26.11% | −118.07% | −304.68% |
| Research & development | $21.2M | $38.4M | $57.3M | $48.9M | $36.7M | $28.9M | $23.3M | $22.9M |
| Operating expenses | $113.5M | $151.9M | $198.8M | $178.9M | $138.1M | $104.4M | $52.5M | $40.4M |
| Operating income | −$66.7M | −$113.4M | −$169.8M | −$161.0M | −$130.5M | −$117.5M | −$70.3M | −$46.6M |
| Operating margin | −55.83% | −99.72% | −130.22% | −139.56% | −127.21% | −235.24% | −466.29% | −2,320.03% |
| EBITDA | −$62.4M | −$107.6M | −$164.0M | −$155.8M | −$125.4M | −$114.3M | −$68.8M | −$45.5M |
| EBITDA margin | −52.20% | −94.69% | −125.76% | −135.08% | −122.18% | −228.91% | −456.45% | −2,266.77% |
| Net income | −$81.7M | −$128.0M | −$172.8M | −$163.0M | −$131.9M | −$121.5M | −$68.3M | −$49.8M |
| Net profit margin | −68.34% | −112.57% | −132.54% | −141.24% | −128.59% | −243.30% | −452.97% | −2,480.32% |
| Basic EPSper basic share | -$5.37 | -$36.96 | -$52.28 | -$50.70 | -$43.35 | -$72.75 | -$1,493.70 | -$1,511.25 |
| Diluted EPSper diluted share | -$5.37 | -$36.96 | -$52.28 | -$50.70 | -$43.35 | -$72.75 | -$1,493.70 | -$1,511.25 |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
Leonard Braden Michael | 2.52M |
Trigg Leslie | 240.28K |
HACKETT PATRICK T | 230.84K |
Gaeta Renee | 185.38K |
Elliott Derick A. | 96K |
Brottem John L. | 90.11K |
LANG BRENT D. | 45.18K |
Nash Marc | 38.39K |
GROSSMAN D KEITH | 37.43K |
OBOYLE KEVIN C | 34.79K |
Prange Karen | 29.33K |
Drexler Karen | 23.4K |
Ahmed Nabeel | 16.1K |
Saia Andrea Lynn | 12.18K |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 3, 2026Form 4 | Gaeta ReneeChief Financial Officer | SellCommon Stock | 17.7K | $4.94 | $87.3K | 113.8K |
| May 15, 2026Form 4 | Trigg LeslieChair and CEO | SellCommon Stock | 3.4K | $3.70 | $12.7K | 98.9K |
| May 15, 2026Form 4 | Nash MarcEVP Operations R&D & Service | SellCommon Stock | 1.6K | $3.70 | $5.9K | 38.4K |
| May 15, 2026Form 4 | Brottem John L.General Counsel | SellCommon Stock | 2.6K | $3.70 | $9.8K | 30.3K |
| Feb 17, 2026Form 4 | Nash MarcEVP Operations R&D & Service | SellCommon Stock | 1.8K | $3.35 | $6.1K | 40.0K |